Solifenacin Succinate Tablets recall: CGMP Deviations
Solifenacin Succinate Tablets, 10 mg, 30-count bottles, Rx Only, Manufactured by: Cipla Ltd., Verna, Goa, India Manufactured for Cipla USA, Inc. 1560…
Why was Solifenacin Succinate Tablets recalled?
CGMP Deviations
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: GG90819, Exp. Date 06/2021
- Product
- Solifenacin Succinate Tablets, 10 mg, 30-count bottles, Rx Only, Manufactured by: Cipla Ltd., Verna, Goa, India Manufactured for Cipla USA, Inc. 1560…
- Recalling firm
- CIPLA
- Quantity
- 7228 bottles
- Distribution
- Nationwide within the United States
- Recall date
- July 21, 2021
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)